ChartRow logo
ChartRow
Stocks and ETFs

RMD

ResMed Inc.StockHealthcare
$188.63+$2.34 (+1.26%)as of Jun 18, 4:00 PM ET

Key stats

Market cap
27.5B
P/E (ttm)
18.1×
Fwd P/E
15.6×
P/S
5.0×
P/B
4.2×
EPS (ttm)
$10.37
EV/EBITDA
13.9×
EV/Sales
4.7×
P/FCF
15.7×
FCF yield
6.38%
Net margin
27.44%
ROE
23.41%
ROA
17.30%
Debt / equity
0.06×
Current ratio
3.01
Beta
0.78
Div yield
1.27%
52W high
-35.80%
Rel volume
2.54×
30D $ vol
301.6M

Performance

1D
+1.26%
1W
-1.95%
1M
-9.22%
3M
-17.05%
YTD
-22.95%
1Y
-24.58%
5Y
-13.70%

Financial statements

Open full RMD financials →

Related Healthcare

1M
TickerThemePrice1M30D $Vol
LLY
Eli Lilly and Company
Pharmaceuticals$1,099+7.55%3.4B
JNJ
Johnson & Johnson
Pharmaceuticals$228-0.70%1.9B
ABBV
AbbVie Inc.
Biopharma$216+1.28%1.2B
UNH
UnitedHealth Group Incorporated Common Stock (DE)
$401+3.01%2.8B
MRK
Merck & Co. Inc.
Pharmaceuticals$114-0.32%1.3B
AMGN
Amgen Inc.
Biotech$338+2.07%997.1M
TMO
Thermo Fisher Scientific Inc.
Life Sciences$465+3.75%1.2B
ABT
Abbott Laboratories
Medical Devices$88.41-0.46%1.2B

ResMed Inc. (RMD) trades at $188.63 with a live price and an interactive chart covering 23+ years of daily price history, plus key valuation metrics. ChartRow also publishes RMD's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full RMD financial statements →